Effective and safe drug therapy in the treatment of Hp-associated diseases of the stomach and duodenum
The introduction of potent antisecretory drugs and eradication therapy (ET) of Helicobacter pylori (HP) [1, 2] in the last decades of the XX century has dramatically changed the pathogenic concept of such HP-associated gastric diseases as chronic gastritis (CG) type B and duodenal ulcer disease (DUD...
Main Authors: | , |
---|---|
Format: | Article |
Language: | Russian |
Published: |
Remedium Group LLC
2014-12-01
|
Series: | Медицинский совет |
Subjects: | |
Online Access: | https://www.med-sovet.pro/jour/article/view/547 |